Signaling pathways
-
BA8582 UtatrectinibSummary: Utatrectinib (AZD-7451) is a potent, selective and orally active inhibitor. - BA8583 ENT-C225Summary: ENT-C225 is a potent neurotrophin receptor activator.
- BA8584 TrkA-IN-4Summary: TrkA-IN-4 is a potent and orally active alterative inhibitor of the precursor (=22.4 nM).
- BA8586 SynuClean-DSummary: SynuClean-D (SC-D) is an inhibitor of α-synuclein aggregation.
- BA8587 ELN484228Summary: ELN484228 is a blocker of alpha-synuclein.
- BA8588 MinzasolminSummary: Inhibitors of alpha-synuclein oligomerization.
- BA8589 BPN-15606Summary: BPN-15606 is a potent oral activity modulator (GSM) that attenuates SHSY5Y neuroblastoma cell production.
- BA8590 PF-06648671Summary: PF-06648671 is a novel, blood-brain barrier permeable, orally active gamma secretase modulator (GSM).
- BA8591 NGP555Summary: NGP555 is a γ-secretase regulator.
- BA8592 FosciclopiroxSummary: Fosciclopirox inhibits the growth of uroepithelial carcinoma by targeting it.